[Current treatment strategies for Parkinson's disease]

MeSH terms

• Aged
• Animals
• Anti-Dyskinesia Agents / therapeutic use
• Antiparkinson Agents / administration & dosage
• Antiparkinson Agents / adverse effects
• Antiparkinson Agents / therapeutic use
• Apomorphine / administration & dosage
• Apomorphine / therapeutic use
• Critical Care
• Deep Brain Stimulation
• Dementia / etiology
• Dementia / therapy
• Depression / drug therapy
• Depression / etiology
• Disruptive, Impulse Control, and Conduct Disorders / etiology
• Disruptive, Impulse Control, and Conduct Disorders / therapy
• Dopamine Agonists / adverse effects
• Dopamine Agonists / therapeutic use
• Europe / epidemiology
• Female
• Humans
• Infusion Pumps, Implantable
• Levodopa / administration & dosage
• Levodopa / adverse effects
• Levodopa / therapeutic use
• Male
• Middle Aged
• Movement Disorders / etiology
• Movement Disorders / therapy
• Parkinson Disease / complications
• Parkinson Disease / diagnosis
• Parkinson Disease / drug therapy
• Parkinson Disease / epidemiology
• Parkinson Disease / therapy*
• Psychotic Disorders / etiology
• Psychotic Disorders / therapy
• Sleep Wake Disorders / etiology
• Sleep Wake Disorders / therapy
• Tremor / drug therapy
• Tremor / etiology